Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021
Recommended Citation
Jain V, Gupta K, Bhatia K, Bansal A, Arora S, Khandelwal AK, Rosenberg JR, Levisay JP, Tommaso CL, Ricciardi MJ, and Qamar A. Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021. Trends Cardiovasc Med 2020.
Document Type
Article
Publication Date
12-15-2020
Publication Title
Trends in cardiovascular medicine
Abstract
As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing possibility that patients with COVID-19 may present with ST-segment elevation myocardial infarction (STEMI). With social distancing and restricted access to preventive healthcare and emergency services, the management of acute cardiac emergencies such as myocardial infarction has suffered collateral damage. Thus far, global trends suggest a decrease in STEMI activations with possible worse outcomes due to delayed presentation and management. In this review, we discuss the challenges to STEMI management in the COVID-19 era and provide potential solutions for adherence to evidence-based therapies as the pandemic progresses into the year 2021.
PubMed ID
33338636
ePublication
ePub ahead of print
